Cargando…

Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma

BACKGROUND: Currently, none of the available colorectal adenocarcinoma (CAC) testing has been established as a well-accepted diagnosis tool, particularly for the early stage of CAC. The recent discovery of serum microRNA (miRNA) profile has provided a new auxiliary approach for tumour diagnosis. Our...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, G, Du, L, Yang, X, Zhang, X, Wang, L, Yang, Y, Li, J, Wang, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229633/ https://www.ncbi.nlm.nih.gov/pubmed/25233400 http://dx.doi.org/10.1038/bjc.2014.489

Ejemplares similares

Serum biomarker panels for the diagnosis of gastric adenocarcinoma
por: Ahn, H S, et al.
Publicado: (2012)

Serum microRNA-210 as a potential noninvasive biomarker for the diagnosis and prognosis of glioma
por: Lai, N-s, et al.
Publicado: (2015)

A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer
por: Zhu, C, et al.
Publicado: (2014)

microRNA-221 and microRNA-18a identification in stool as potential biomarkers for the non-invasive diagnosis of colorectal carcinoma
por: Yau, T O, et al.
Publicado: (2014)

Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer
por: Matsumura, T, et al.
Publicado: (2015)

Dynamic plasma microRNAs are biomarkers for prognosis and early detection of recurrence in colorectal cancer
por: Yuan, Zixu, et al.
Publicado: (2017)

Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: a systematic review and meta-analysis
por: Carter, Jane V, et al.
Publicado: (2017)

Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer
por: Wang, M, et al.
Publicado: (2014)

MicroRNA expression profiling identifies miR-328 regulates cancer stem cell-like SP cells in colorectal cancer
por: Xu, X T, et al.
Publicado: (2012)

MicroRNA-29a promotes colorectal cancer metastasis by regulating matrix metalloproteinase 2 and E-cadherin via KLF4
por: Tang, W, et al.
Publicado: (2014)

COUP-TFII regulates metastasis of colorectal adenocarcinoma cells by modulating Snail1
por: Bao, Y, et al.
Publicado: (2014)

Identification of serum microRNA profiles in colon cancer
por: Hofsli, E, et al.
Publicado: (2013)

C/EBP-β-activated microRNA-223 promotes tumour growth through targeting RASA1 in human colorectal cancer
por: Sun, D, et al.
Publicado: (2015)

Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel
por: Oikonomopoulou, K, et al.
Publicado: (2008)

Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis
por: Xue, A, et al.
Publicado: (2010)

Testing breast cancer serum biomarkers for early detection and prognosis in pre-diagnosis samples
por: Kazarian, Anna, et al.
Publicado: (2017)

Circulating microRNAs as biomarkers for early detection of diffuse-type gastric cancer using a mouse model
por: Rotkrua, P, et al.
Publicado: (2013)

Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation
por: Sugimachi, K, et al.
Publicado: (2015)

Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients
por: Summerer, I, et al.
Publicado: (2015)

MicroRNA-196a promotes cervical cancer proliferation through the regulation of FOXO1 and p27(Kip1)
por: Hou, T, et al.
Publicado: (2014)

MicroRNA-145 inhibits tumour growth and metastasis in colorectal cancer by targeting fascin-1
por: Feng, Y, et al.
Publicado: (2014)

Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma
por: Takeshita, N, et al.
Publicado: (2013)

Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma
por: Jones, C I, et al.
Publicado: (2012)

MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer
por: Ng, E K O, et al.
Publicado: (2009)

MicroRNA-183 promotes proliferation and invasion in oesophageal squamous cell carcinoma by targeting programmed cell death 4
por: Ren, L-H, et al.
Publicado: (2014)

MicroRNA profiling in clear cell renal cell carcinoma tissues potentially links tumorigenesis and recurrence with obesity
por: Shu, X, et al.
Publicado: (2017)

Panel of serum biomarkers (GastroPanel) in diagnosis of atrophic gastritis and Helicobacter pylori infection: a protocol of systematic review and meta-analysis
por: Wu, Dan, et al.
Publicado: (2022)

MicroRNA profile: a promising ancillary tool for accurate renal cell tumour diagnosis
por: Silva-Santos, R M, et al.
Publicado: (2013)

A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline
por: Liu, Xiaohui, et al.
Publicado: (2017)

FMNL2 destabilises COMMD10 to activate NF-κB pathway in invasion and metastasis of colorectal cancer
por: Yang, S S, et al.
Publicado: (2017)

MiR-224 promotes the chemoresistance of human lung adenocarcinoma cells to cisplatin via regulating G(1)/S transition and apoptosis by targeting p21(WAF1/CIP1)
por: Wang, H, et al.
Publicado: (2014)

Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53
por: Millar, E K A, et al.
Publicado: (2011)

Predictive value of miR-9 as a potential biomarker for nasopharyngeal carcinoma metastasis
por: Lu, J, et al.
Publicado: (2014)

MicroRNA-100/99a, deregulated in acute lymphoblastic leukaemia, suppress proliferation and promote apoptosis by regulating the FKBP51 and IGF1R/mTOR signalling pathways
por: Li, X-J, et al.
Publicado: (2013)

A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours
por: Russell, Matthew R, et al.
Publicado: (2017)

MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours
por: Dieckmann, K-P, et al.
Publicado: (2012)

Jumonji domain-containing protein 2B silencing induces DNA damage response via STAT3 pathway in colorectal cancer
por: Chen, L, et al.
Publicado: (2014)

Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c
por: Nygren, M K, et al.
Publicado: (2014)

Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma
por: Konishi, H, et al.
Publicado: (2012)

Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer
por: Miyamae, Mahito, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_o79kdo3l6i3fdt8or0c9plqo1f